메뉴 건너뛰기




Volumn 18, Issue 10, 2012, Pages 1412-1421

Natural, innate improvements in multiple sclerosis disability

Author keywords

disability; disease progression; improvement; innate improvement; Multiple sclerosis; natural history

Indexed keywords

ARTICLE; DATA BASE; DISABILITY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RELAPSE; SCORING SYSTEM;

EID: 84866984858     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512439119     Document Type: Article
Times cited : (23)

References (32)
  • 1
    • 18844365126 scopus 로고    scopus 로고
    • Multiple sclerosis: Diagnosis and the management of acute relapses
    • Leary SM, Porter B, Thompson AJ. Multiple sclerosis: Diagnosis and the management of acute relapses. Postgrad Med J. 2005 ; 81: 302-308
    • (2005) Postgrad Med J , vol.81 , pp. 302-308
    • Leary, S.M.1    Porter, B.2    Thompson, A.J.3
  • 2
    • 0034101317 scopus 로고    scopus 로고
    • Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: Effects of heterogeneity of disease course in placebo cohorts
    • Liu C, Blumhardt LD. Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: Effects of heterogeneity of disease course in placebo cohorts. J Neurol Neurosurg Psychiatry. 2000 ; 68: 450-457
    • (2000) J Neurol Neurosurg Psychiatry , vol.68 , pp. 450-457
    • Liu, C.1    Blumhardt, L.D.2
  • 3
    • 52449117054 scopus 로고    scopus 로고
    • Disability as an outcome in MS clinical trials
    • Ebers GC, Heigenhauser L, Daumer M, et al. Disability as an outcome in MS clinical trials. Neurology. 2008 ; 71: 624-631
    • (2008) Neurology , vol.71 , pp. 624-631
    • Ebers, G.C.1    Heigenhauser, L.2    Daumer, M.3
  • 4
    • 0029082566 scopus 로고
    • Copolymer i reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicentre, double-blind placebo-controlled trial
    • Johnson KP, Brooks BR, Cohen JA, et al. Copolymer I reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicentre, double-blind placebo-controlled trial. Neurology. 1995 ; 45: 1268-1276
    • (1995) Neurology , vol.45 , pp. 1268-1276
    • Johnson, K.P.1    Brooks, B.R.2    Cohen, J.A.3
  • 5
    • 84877008183 scopus 로고    scopus 로고
    • An extension protocol for multiple sclerosis patients who participated in Genzyme-sponsored studies of alemtuzumab. Sponsor: Genzyme; Collaborator: Bayer. ClinicalTrials.gov Identifier: NCT00930553 2010, accessed 8 November 2010
    • An extension protocol for multiple sclerosis patients who participated in Genzyme-sponsored studies of alemtuzumab. Sponsor: Genzyme; Collaborator: Bayer. ClinicalTrials.gov Identifier: NCT00930553http://clinicaltrials.gov/ct2/ show/NCT00930553?term=Multiple+Sclerosis,+edss+reduction&outc=EDSS&rank= 8 (2010, accessed 8 November 2010).
  • 6
    • 79952740129 scopus 로고    scopus 로고
    • Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: Post-hoc andsubset analyses of clinical efficacy outcomes
    • Coles AJ, Fox E, Vladic A, et al. Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: Post-hoc andsubset analyses of clinical efficacy outcomes. Lancet Neurol. 2011 ; 10: 338-348
    • (2011) Lancet Neurol , vol.10 , pp. 338-348
    • Coles, A.J.1    Fox, E.2    Vladic, A.3
  • 7
    • 0021035886 scopus 로고
    • Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
    • Kurtzke J. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452
    • (1983) Neurology , vol.33 , pp. 1444-1452
    • Kurtzke, J.1
  • 8
    • 72449125358 scopus 로고    scopus 로고
    • Multiple sclerosis risk sharing scheme: Two year results of clinical cohort study with historical comparator
    • Boggild M, Palace J, Barton P, et al. Multiple sclerosis risk sharing scheme: Two year results of clinical cohort study with historical comparator. BMJ. 2009 ; 339: b4677
    • (2009) BMJ , vol.339 , pp. 4677
    • Boggild, M.1    Palace, J.2    Barton, P.3
  • 9
    • 0022629588 scopus 로고
    • Prevalence of multiple sclerosis in British Columbia, Canada
    • Sweeney VP, Sadovnick AD, Brandejs V. Prevalence of multiple sclerosis in British Columbia, Canada. Can J Neurol Sci. 1986 ; 13: 47-51
    • (1986) Can J Neurol Sci , vol.13 , pp. 47-51
    • Sweeney, V.P.1    Sadovnick, A.D.2    Brandejs, V.3
  • 10
    • 0026780512 scopus 로고
    • Life expectancy in patients attending multiple sclerosis clinics
    • Sadovnick AD, Ebers GC, Wilson RW, et al. Life expectancy in patients attending multiple sclerosis clinics. Neurology. 1992 ; 42: 991-994
    • (1992) Neurology , vol.42 , pp. 991-994
    • Sadovnick, A.D.1    Ebers, G.C.2    Wilson, R.W.3
  • 11
    • 33644887189 scopus 로고    scopus 로고
    • Disability progression in multiple sclerosis is slower than previously reported
    • Tremlett H, Paty D, Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology. 2006 ; 66: 172-177
    • (2006) Neurology , vol.66 , pp. 172-177
    • Tremlett, H.1    Paty, D.2    Devonshire, V.3
  • 12
    • 77953750773 scopus 로고    scopus 로고
    • New perspectives in the natural history of multiple sclerosis
    • Tremlett H, Zhao Y, Rieckmann P, et al. New perspectives in the natural history of multiple sclerosis. Neurology. 2010 ; 74: 2004-2015
    • (2010) Neurology , vol.74 , pp. 2004-2015
    • Tremlett, H.1    Zhao, Y.2    Rieckmann, P.3
  • 13
    • 0020686503 scopus 로고
    • New diagnostic criteria for multiple sclerosis: Guidelines for research proposals
    • Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research proposals. Ann Neurol. 1983 ; 13: 227-231
    • (1983) Ann Neurol , vol.13 , pp. 227-231
    • Poser, C.M.1    Paty, D.W.2    Scheinberg, L.3
  • 15
    • 0024205301 scopus 로고
    • Models for longitudinal data: A generalized estimating equation approach
    • Zeger SL, Liang KY, Albert PS. Models for longitudinal data: A generalized estimating equation approach. Biometrics. 1988 ; 44: 1049-1060
    • (1988) Biometrics , vol.44 , pp. 1049-1060
    • Zeger, S.L.1    Liang, K.Y.2    Albert, P.S.3
  • 16
    • 0027053029 scopus 로고
    • An overview of methods for the analysis of longitudinal data
    • Zeger SL, Liang KY. An overview of methods for the analysis of longitudinal data. Stat Med. 1992 ; 11: 1825-1839
    • (1992) Stat Med , vol.11 , pp. 1825-1839
    • Zeger, S.L.1    Liang, K.Y.2
  • 17
    • 0029913882 scopus 로고    scopus 로고
    • Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis
    • Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
    • (1996) Neurology , vol.46 , pp. 907-911
    • Lublin, F.D.1    Reingold, S.C.2
  • 18
    • 77957044257 scopus 로고    scopus 로고
    • Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity
    • Jones JL, Anderson JM, Phuah CL, et al. Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. Brain. 2010 ; 133: 2232-2247
    • (2010) Brain , vol.133 , pp. 2232-2247
    • Jones, J.L.1    Anderson, J.M.2    Phuah, C.L.3
  • 19
    • 79953761792 scopus 로고    scopus 로고
    • A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
    • Nikic I, Merkler D, Sorbara C, et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med. 2011 ; 17: 495-499
    • (2011) Nat Med , vol.17 , pp. 495-499
    • Nikic, I.1    Merkler, D.2    Sorbara, C.3
  • 20
    • 79959744924 scopus 로고    scopus 로고
    • Enhancing remyelination in disease-can we wrap it up?
    • Kotter MR, Stadelmann C, Hartung HP. Enhancing remyelination in disease-can we wrap it up?. Brain. 2011 ; 134: 1882-1900
    • (2011) Brain , vol.134 , pp. 1882-1900
    • Kotter, M.R.1    Stadelmann, C.2    Hartung, H.P.3
  • 21
    • 0024586487 scopus 로고
    • Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients
    • Willoughby EW, Grochowski E, Li DK, et al. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients. Ann Neurol. 1989 ; 25: 43-49
    • (1989) Ann Neurol , vol.25 , pp. 43-49
    • Willoughby, E.W.1    Grochowski, E.2    Li, D.K.3
  • 22
    • 0025314243 scopus 로고
    • Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group
    • Noseworthy JH, Vandervoort MK, Wong CJ, et al. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology. 1990 ; 40: 971-975
    • (1990) Neurology , vol.40 , pp. 971-975
    • Noseworthy, J.H.1    Vandervoort, M.K.2    Wong, C.J.3
  • 23
    • 0026844653 scopus 로고
    • Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group
    • Goodkin DE, Cookfair D, Wende K, et al. Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group. Neurology. 1992 ; 42: 859-863
    • (1992) Neurology , vol.42 , pp. 859-863
    • De, G.1    Cookfair, D.2    Wende, K.3
  • 24
    • 0029131208 scopus 로고
    • Measuring patient-centered outcomes in neurologic disease. Extending the Q-TWiST method
    • Schwartz CE, Cole BF, Gelber RD. Measuring patient-centered outcomes in neurologic disease. Extending the Q-TWiST method. Arch Neurol. 1995 ; 52: 754-762
    • (1995) Arch Neurol , vol.52 , pp. 754-762
    • Schwartz, C.E.1    Cole, B.F.2    Gelber, R.D.3
  • 25
    • 0028928973 scopus 로고
    • The natural history of multiple sclerosis
    • Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin. 1995 ; 13: 119-146
    • (1995) Neurol Clin , vol.13 , pp. 119-146
    • Weinshenker, B.G.1
  • 26
    • 0025978558 scopus 로고
    • An assessment of disability rating scales used in multiple sclerosis
    • Francis DA, Bain P, Swan AV, et al. An assessment of disability rating scales used in multiple sclerosis. Arch Neurol. 1991 ; 48: 299-301
    • (1991) Arch Neurol , vol.48 , pp. 299-301
    • Francis, D.A.1    Bain, P.2    Swan, A.V.3
  • 27
    • 0026024427 scopus 로고
    • Observer disagreement in rating neurologic impairment in multiple sclerosis: Facts and consequences
    • Verdier-Taillefer MH, Zuber M, Lyon-Caen O, et al. Observer disagreement in rating neurologic impairment in multiple sclerosis: Facts and consequences. Eur Neurol. 1991 ; 31: 117-119
    • (1991) Eur Neurol , vol.31 , pp. 117-119
    • Verdier-Taillefer, M.H.1    Zuber, M.2    Lyon-Caen, O.3
  • 28
    • 0030911461 scopus 로고    scopus 로고
    • Primary progressive multiple sclerosis
    • Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain. 1997 ; 120: 1085-1096
    • (1997) Brain , vol.120 , pp. 1085-1096
    • Thompson, A.J.1    Polman, C.H.2    Miller, D.H.3
  • 29
    • 0032946328 scopus 로고    scopus 로고
    • The natural history of multiple sclerosis: A geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis
    • Cottrell DA, Kremenchutzky M, Rice GP, et al. The natural history of multiple sclerosis: A geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain. 1999 ; 122: 625-639
    • (1999) Brain , vol.122 , pp. 625-639
    • Cottrell, D.A.1    Kremenchutzky, M.2    Rice, G.P.3
  • 30
    • 3042601982 scopus 로고    scopus 로고
    • The PROMiSe trial: Baseline data review and progress report
    • Wolinsky JS. The PROMiSe trial: Baseline data review and progress report. Mult Scler. 2004 ; 10 (Suppl. 1). S65 - S71
    • (2004) Mult Scler , vol.10 , Issue.SUPPL. 1
    • Wolinsky, J.S.1
  • 31
    • 70149121896 scopus 로고    scopus 로고
    • Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
    • Burton JM, O'Connor PW, Hohol M, et al. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst Rev. 2009 ;: CD006921
    • (2009) Cochrane Database Syst Rev , pp. 006921
    • Burton, J.M.1    O'Connor, P.W.2    Hohol, M.3
  • 32
    • 0028279178 scopus 로고
    • Establishment and use of multiple sclerosis registers-EDMUS
    • Confavreux C. Establishment and use of multiple sclerosis registers-EDMUS. Ann Neurol. 1994 ; 36: S136 - S139
    • (1994) Ann Neurol , vol.36
    • Confavreux, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.